Time to question the NHS diabetes prevention programme

BMJ (Online)

Volumn 351, Issue , 2015, Pages

  Barry, Eleanor ^a   Roberts, Samantha ^a   Finer, Sarah ^b   Vijayaraghavan, Shanti ^c   Greenhalgh, Trisha ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NEWHAM UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

BEHAVIOR CHANGE; BEHAVIOR MODIFICATION; BLOOD ANALYSIS; DIET THERAPY; EDITORIAL; EXERCISE; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INDIVIDUALIZATION; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; NATIONAL HEALTH SERVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; UNITED KINGDOM; WEIGHT REDUCTION; DIABETES MELLITUS, TYPE 2; ORGANIZATION AND MANAGEMENT; PREVALENCE; PROGRAM EVALUATION;

DIABETES MELLITUS, TYPE 2; GREAT BRITAIN; HUMANS; PREVALENCE; PROGRAM EVALUATION; STATE MEDICINE;

EID: 84947813937     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h4717     Document Type: Editorial

References (31)

1. National Cardiovascular Intelligence Network. NHS Diabetes Prevention Programme (NHS DPP) Non-diabetic hyperglycaemia. Public Health England, 2015.
2. NHS England. NHS Diabetes Prevention Programme. 2015. www.england.nhs.uk/ourwork/qual-clin-lead/action-for-diabetes/diabetes-prevention/.
3. World Health Organisation. Global status report on noncommunicable diseases 2014. www.who.int/nmh/publications/ncd-status-report-2014/en/.
4. Green T. Diabetes-the case for considering context. 2015. www.rwjf.org/en/culture-ofhealth/2015/01/diabetes-the-casef.html.
5. Buijsse B, Simmons RK, Griffin SJ, et al. Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 2011;33:46-62.
6. Kengne AP, Beulens JW, Peelen LM, et al. Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol 2014;2:19-29.
7. Noble D, Mathur R, Dent T, et al. Risk models and scores for type 2 diabetes: systematic review. BMJ 2011;343:d7163.
8. Collins GS, Mallett S, Omar O, et al. Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med 2011;9:103.
9. Bellamy L, Casas J-P, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773-9.
10. Yudkin JS, Montori VM. The epidemic of pre-diabetes: the medicine and the politics. BMJ 2014;349:g4485.
11. Selvin E, Rawlings AM, Bergenstal RM, et al. No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes. Diabetes Care 2013;36:2995-3001.
12. Kim C, Bullard KM, Herman WH, et al. Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care 2010;33:780-5.
13. Kim PS, Woods C, Georgoff P, et al. A1C underestimates glycemia in HIV infection. Diabetes Care 2009;32:1591-3.
14. Behan KJ, Merschen J. HbA1c does not always estimate average glucose. Clin Lab Sci 2011;24:71-7.
15. Ashra NB, Spong R, Carter P, et al. A systematic review and meta-analysis assessing the effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes mellitus in routine practice. 2015. www.gov.uk/government/publications/diabetesprevention-programmes-evidence-review.
16. Dunkley AJ, Bodicoat DH, Greaves CJ, et al. Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations a systematic review and meta-analysis. Diabetes Care 2014;37:922-33.
17. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 2005;365:82-93.
18. Society for Women's Health Research, United States Food and Drug Administration Office of Women's Health. Dialogues on diversifying clinical trials. 2012. www.fda.gov/downloads/scienceresearch/specialtopics/womenshealthresearch/ucm334959.pdf.
19. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 2008;112:228-42.
20. Yates T, Davies M, Gorely T, et al. Effectiveness of a pragmatic education program designed to promote walking activity in individuals with impaired glucose tolerance a randomized controlled trial. Diabetes Care 2009;32:1404-10.
21. Bhopal RS, Douglas A, Wallia S, et al. Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes Endocrinol 2014;2:218-27.
22. Oldroyd JC, Unwin NC, White M, et al. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract 2006;72:117-27.
23. Cohn S, Clinch M, Bunn C, et al. Entangled complexity: why complex interventions are just not complicated enough. J Health Serv Res Policy 2013;18:40-3.
24. Mackenzie M, O'Donnell C, Halliday E, et al. Do health improvement programmes fit with MRC guidance on evaluating complex interventions? BMJ 2010;340:c185.
25. Petticrew M. When are complex interventions "complex"? When are simple interventions "simple"? Eur J Public Health 2011;21:397-8.
26. Hawe P. Lessons from complex interventions to improve health. Public Health 2015;36:307.
27. Selph S, Dana T, Blazina I, et al. Screening for type 2 diabetes mellitus: a systematic review for the US Preventive Services Task Force. Ann Intern Med 2015;162:765-76.
28. Ioannidis JP. Why most published research findings are false. PLoS Med 2005;2:e124.
29. Hill JO, Galloway JM, Goley A, et al. Scientific statement: socioecological determinants of prediabetes and type 2 diabetes. Diabetes Care 2013;36:2430-9.
30. Unwin N, Whiting D, Roglic G. Social determinants of diabetes and challenges of prevention. Lancet 2010;375:2204-5.
31. Christine PJ, Auchincloss AH, Bertoni AG, et al. Longitudinal associations between neighborhood physical and social environments and incident type 2 diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis (MESA). JAMA Intern Med 2015;175:1311-20.